BNBX
BNB Plus Corp.
NASDAQ · Healthcare · Biotechnology · US
$0.16
+0.00%Margins
Gross margin
43.5%
EBITDA margin
-1657.6%
EBIT margin
-1209.5%
Net margin
-1646.9%
FCF margin
-659.2%
-275.7%
Return on equity
-252.9%
Return on assets
-202.5%
Return on invested capital
0.12x
Asset turnover
-$13.8M
Cash from operations
$0.17
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026